NCT05115006View on ClinicalTrials.gov

A Study of Adjuvant Melanoma Stakeholder Treatment Preferences

CompletedOBSERVATIONAL
Enrollment

294

Participants

Timeline

Start Date

January 7, 2021

Primary Completion Date

June 2, 2022

Study Completion Date

June 2, 2022

Conditions
Melanoma
Trial Locations (1)

3084

Local Institution, Melbourne

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT05115006 - A Study of Adjuvant Melanoma Stakeholder Treatment Preferences | Biotech Hunter | Biotech Hunter